SCHEMBL5578159

SCHEMBL5578159

O=C(O)COc1ccc(-c2cncn2-c2n[nH]c3nc(NC(=O)C4CC4)sc23)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CLK1 P49759 1/20 0.36
JAK1 P23458 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
ABL1 P00519 9/20 0.35
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
MAP4K1 Q92918 1/20 0.34
FABP1 P07148 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14454892 0.94 MEN1 (0.38) MEN1KMT2ACLK1JAK1KDM4E
SCHEMBL14454904 0.91 CLK1 (0.37) MEN1KMT2ACLK1JAK1KDM4E
SCHEMBL14454900 0.91 MAOB (0.39) MEN1KMT2AALDH1A1MAPTABL1
SCHEMBL14454902 0.91 CLK1 (0.38) MEN1KMT2ACLK1JAK1KDM4E
SCHEMBL14454970 0.91 ABL1 (0.37) MEN1KMT2ACLK1JAK1KDM4E
SCHEMBL14454901 0.90 CLK1 (0.39) MEN1KMT2ACLK1JAK1KDM4E
SCHEMBL5578089 0.90 CLK1 (0.36) MEN1KMT2ACLK1JAK1KDM4E
SCHEMBL14454934 0.90 MEN1 (0.36) MEN1KMT2ACLK1JAK1KDM4E
SCHEMBL14454890 0.89 KMT2A (0.42) MEN1KMT2ACLK1ALDH1A1MAPT
SCHEMBL14454932 0.89 CLK1 (0.38) MEN1KMT2ACLK1JAK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
WO-2007059341-A2 PYRAZOLOTHIAZOLE PROTEIN KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 MEN1 3359/4885KMT2A 1434/4885CLK1 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.